Evidence map›Paper›PMID 28893998›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

Engineering a light-activated caspase-3 for precise ablation of neurons in vivo.

Ashley D Smart, Roland A Pache, Nathan D Thomsen, Tanja Kortemme, Graeme W Davis, James A Wells

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Optogenetic enzymes: A deep dive into design and impact.Current opinion in structural biology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Cell survival following direct executioner-caspase activation.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. A photo-switchable assay system for dendrite degeneration and repair inProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Review
  15. Article
  16. CRISPR-Based Transcriptional Activation in Drosophila.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  17. Protein-protein interaction prediction with deep learning: A comprehensive review.Computational and structural biotechnology journal · 2022
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ashley D SmartDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Roland A PacheDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94158.
Nathan D ThomsenDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158.
Tanja KortemmeDepartment of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94158.
Graeme W DavisDepartment of Biochemistry and Biophysics, University of California, San Francisco, CA 94158; graeme.davis@ucsf.edu jim.wells@ucsf.edu.
James A WellsDepartment of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158; graeme.davis@ucsf.edu jim.wells@ucsf.edu.
University of California, San Francisco · US

Funding

Homeostatic Stabilization of Neural Function in Health and DiseaseR35NS097212 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DAVIS, GRAEME W · 2017 to 2024
$9.2M
Global Analysis of Proteolysis in ApoptosisR01GM081051 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WELLS, JAMES A · 2007 to 2015
$2.8M
Molecular and Cellular Mechanisms of Synaptic GrowthR37NS047342 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DAVIS, GRAEME W · 2013 to 2016
$1.4M
Regulating Proteolysis to Dissect ApoptosisR01GM097316 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WELLS, JAMES A · 2011 to 2014
$1.1M
High Performance Computer for Computational BiosciencesS10OD021596 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SALI, ANDREJ · 2016 to 2016
$443k
NIGMS NIH HHS R01 GM081051NIGMS NIH HHS R01 GM097316NIH HHS S10 OD021596NINDS NIH HHS R35 NS097212NINDS NIH HHS R37 NS047342
6 · The paper itself

Abstract

The circuitry of the brain is characterized by cell heterogeneity, sprawling cellular anatomy, and astonishingly complex patterns of connectivity. Determining how complex neural circuits control behavior is a major challenge that is often approached using surgical, chemical, or transgenic approaches to ablate neurons. However, all these approaches suffer from a lack of precise spatial and temporal control. This drawback would be overcome if cellular ablation could be controlled with light. Cells are naturally and cleanly ablated through apoptosis due to the terminal activation of caspases. Here, we describe the engineering of a light-activated human caspase-3 (Caspase-LOV) by exploiting its natural spring-loaded activation mechanism through rational insertion of the light-sensitive LOV2 domain that expands upon illumination. We apply the light-activated caspase (Caspase-LOV) to study neurodegeneration in larval and adult

Indexed as

LightAblation TechniquesAnimalsAnimals, Genetically ModifiedApoptosisBrainCaspase 3CaspasesDNA-Binding ProteinsDrosophila melanogasterDrosophila ProteinsEnzyme ActivationMotor NeuronsNeural ConductionRNA InterferenceRNA, Small InterferingCaspase 3CaspasesDcp-1 protein, DrosophilaDNA-Binding Proteinsdronc protein, DrosophilaDrosophila Proteinsp35 protein, BaculovirusRNA, Small InterferingViral ProteinsapoptosisDrosophilaneurodegenerationoptogeneticsprotein engineering

Identifiers

PMID28893998
PMCPMC5625904
OpenAlexW2754057938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.